Jump to content

mansipan

Members
  • Posts

    18
  • Joined

  • Last visited

Posts posted by mansipan

  1. it is usually a non-issue as the efficiency of the whole cloning experiments tends to be way lower than that of the mismatch rate. You have a slightly higher chance of creating some false products, but depending on how the designers are designed and how the cloning is going to proceed you will end up with the vast majority of the correct product for cloning. Since you have to run controls anyway, the probability of PCR purity being the culprit for failed cloning is very low.

    There are exceptions however, e.g. if you do some tricky amplifications with very low yields. Salts or impurities themselves are no issue at all as you do a cleanup post-PCR,

    Thanku very much

  2. For PCR its ok i know but i want to know for further cloning, whether one should go for purification of primers. Is it so that, desalted primer PCR amplified genes give problem in cloning.

     

    Reference: Invitrogen

    Cartridge, HPLC, and PAGE-purified oligos are best for the greatest efficiency. Since oligos are synthesized 3´ to 5´, incomplete oligos (n-x oligos) will be missing the 5´ sequence. It is important to use full-length oligos that have the 5´ sequence present, otherwise there will be a population of PCR products missing the sequence intended to be installed before PCR"

  3. After designing a primer there are different purity grades available according to the purification protocols adopted like, desalting, reverse phase cartridge purification, RP-HPLC, AX-HPLC, PAGE and Gel filtration. my question is how much purity or which purification procedure of primers is good enough for amplifying a gene for cloning purpose.

  4. During my research i came across a peptide* in a research article# which is surprisingly stable to proteolytic enzymes with normal amino acids. Its an antimicrobial peptide which is resistant to the proteolytic enzymes pepsin, trypsin, chymotrypsin, proteinase K and pronase and broad pH stability. How can this be possible that these enzyme are not able to act at their specific site even though no protecting group is present.


    * MACQCPDAISGWTHTDYQCHGLENKMYRHVYAICMNGTQVYCRTEWGSSC

    2012P Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.pdf

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.